Cannabidiol: promise and pitfalls.

Author(s): Welty TE, Luebke A, Gidal BE

Professor and Chair, Department of Clinical Sciences, College of Pharmacy and Health Sciences, Drake University, Des Moines, IA., School of Pharmacy, University of Wisconsin, Madison, WI., Professor and Chair, Division of Pharmacy Practice, School of Pharmacy, University of Wisconsin, Madison, WI.

Subject: Epilepsy View the study


Over the past few years, increasing public and political pressure has supported legalization of medical marijuana. One of the main thrusts in this effort has related to the treatment of refractory epilepsy-especially in children with Dravet syndrome-using cannabidiol (CBD). Despite initiatives in numerous states to at least legalize possession of CBD oil for treating epilepsy, little published evidence is available to prove or disprove the efficacy and safety of CBD in patients with epilepsy.

Source: Epilepsy Currents
Share Tweet

More medical studies related to Epilepsy:

View all medical studies >>

Subscribe for daily cannabis news, announcements, and business insights.